Professor Robina Coker

Robina Coker is Professor of Practice in Respiratory Medicine at Hammersmith Hospital, Imperial College Healthcare NHS Trust, and Imperial College London. She has run the ILD service at Hammersmith Hospital since 1999.  It now operates 8 clinics a week; ILD Clinical Nurse Specialists and a Pharmacist run their own additional clinics. There is a weekly ILD MDT and a monthly cross-site cardiac sarcoid MDT. The Trust service is commissioned as a specialist ILD service by NHS England. In 1999 Robina Coker established and chaired the British Thoracic Society (BTS) Air Travel Working Party, which published the first UK recommendations on air travel and lung disease in 2002. They were the first worldwide to give advice for passengers with a wide range of respiratory conditions. They were revised in 2004 and 2011. Robina chaired the group which wrote the BTS Clinical Statement on Air Travel and Lung Disease, published in Thorax in 2022. In 2019 she was awarded the Individual Bronze Medal by the Royal Aeronautical Society (RAeS) for her contribution to airline passenger safety, and in 2021 she received the BTS Meritorious Service Award. Recent publications Feary J, Devaraj A, Burton M et al . Artificial stone silicosis: a UK case series. Thorax 2024 in press   Jesuthasan A, Baheerathan A, Auger S et al. Methotrexate for the neurologist. Practical Neurology 2024. https://doi.org/10.1136/pn-2024-004156   Kumar K, Ratnakumar R, Collin SM, Berrocal-Almanza LC, Ricci P, Al-Zubaidy M, Coker RK et al .  Chest CT features and functional correlates of COVID-19 at 3 and 12 months follow-up.  Clin Med 2023. https://doi.org/10.7861/clinmed.2023-0059 Coker RK, Armstrong A, Church C et al . British Thoracic Society Clinical Statement on Air Travel for Passengers with Respiratory Disease. Thorax 2022 . doi:10.1136/thoraxjnl-2021-281110   Drake TM, Docherty AB, Harrison EM et al . Outcome of hospitalisation for COVID-19 in patients with interstitial lung disease. Am J Respir Crit Care Med 2020; 202:1656-1665   Wilson A, Clark AB, Cahn T et al. Effect of co-trimoxazole vs placebo on death, lung transplant or hospital admission in patients with IPF. J Am Med Assoc 2020; 324: 2282-2291   Kumar K, Mak V, Groom K et al . Respiratory specialists working in different ways: Development of a GP hotline and respiratory support service during the COVID-19 pandemic. Future Healthc J 2020; 7(3): e88-92 Thickett D, Voorham J, Ryan R et al . Historical database cohort study addressing the clinical patterns prior to IPF diagnosis in UK primary care. BMJ Open 2020;10: e034428 Coker RK, Armstrong A, Church C et al . Points to consider when planning air travel by passengers with respiratory disease during Covid-19. https://www.brit-thoracic.org.uk/quality-improvement/clinical-statements/air-travel/

Interstitial lung disease including idiopathic pulmonary fibrosis (IPF) Sarcoidosis Air travel and lung disease